Pomerantz Law Firm Issues Investor Alert Regarding Perrigo Lawsuit and Class Action Deadlines

Investor Alert: Class Action Lawsuit Against Perrigo Company plc

On November 18, 2025, Pomerantz LLP, a well-respected law firm known for its focus on securities litigation, announced the filing of a class action lawsuit against Perrigo Company plc, trading under the ticker PRGO on the NYSE. This legal action comes in the wake of significant stock price declines attributed to the company's operational failures and mismanagement disclosures.

Background of the Lawsuit

The class action aims to address serious allegations that Perrigo and its executives were involved in securities fraud and other potentially unlawful business activities. Investors who suffered losses due to stock price falls are encouraged to contact the firm, indicating their interest in joining the lawsuit, which could offer them restitution for losses incurred during the class period.

Individuals interested in pursuing claims have until January 16, 2026, to petition for designation as Lead Plaintiff. As noted by Pomerantz, those contemplating action should provide comprehensive information about their investments in Perrigo to facilitate the process.

Recent Stock Volatility

Perrigo's volatile share price has been particularly alarming for investors. In February 2024, upon reporting its fiscal year 2023 earnings, the company revealed substantial charges related to acquisitions and integration processes. The firm reported a significant $35 to $45 million cash cost aimed at resolving production issues in its infant formula sector, leading to a staggering 50% drop in earnings per share compared to the previous year. Following this announcement, Perrigo's stock price plummeted by 15.14%, closing at $27.30 per share.

The downward trend continued, as a May 2024 earnings report further highlighted Perrigo’s struggles. The company's attempts to rectify issues within its infant formula business led to a $3.28 decrease in stock value, representing a 9.8% drop, landing the shares at $30.15.

In August 2025, another disappointing quarterly report revealed a further decline in adjusted gross profits, recognizing $30 million lost due to production inconsistencies, which caused shareholders additional concerns as it led to another dip of 11.31% in share price.

Finally, in November 2025, with a press release citing the initiation of a comprehensive review of its infant formula sector, Perrigo's stock sank 25.2% to close at $15.10. This considerable decline underscores the company’s apparent strategic missteps and operational challenges, prompting investor fears of continued losses.

The Role of Pomerantz LLP

With a legacy spanning over 85 years, Pomerantz LLP has established itself as a leading player in corporate, securities, and antitrust class litigation. The firm, founded by the late Abraham L. Pomerantz—a pioneer in the securities class action domain—continues to champion the rights of investors who find themselves victimized by corporate fraud. Their track record of securing substantial damages for class members emphasizes their commitment and expertise in this intricate field of law.

As the situation surrounding Perrigo unfolds, investors are advised to stay informed on the latest developments and consider their options to secure their financial interests. Potential members of the class action or those affected by Perrigo’s recent disclosure can find further resources, including access to the complaint and participation details, at the Pomerantz website.

Taking Action

It is imperative for investors to act swiftly to protect their investments. Interested parties should reach out to Danielle Peyton at Pomerantz at [email protected] or call 646-581-9980. The firm encourages all investors to have their details ready to ensure efficient processing of their claims and involvement in the class action suit.

In light of these developments, the ongoing class action against Perrigo serves as a significant reminder of the risks associated with investing in publicly traded companies, especially in volatile markets.

For more on Pomerantz and their ongoing efforts in securities litigation, visit their official site at www.pomerantzlaw.com.